Global Transdermal Patch for Pain Relief Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Patch for Pain Relief Market Research Report 2024
Pain Relief patch is a kind of adhesive patch that sticks to the skin and can deliver a specific dose of medicine to the body through the skin. Usually, this promotes the healing of injured parts of the body.
According to Mr Accuracy reports new survey, global Transdermal Patch for Pain Relief market is projected to reach US$ 6315 million in 2029, increasing from US$ 4830.4 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transdermal Patch for Pain Relief market research.
The transdermal patch market is driven by the growing demand for convenient and non-invasive drug delivery methods. These patches offer advantages such as controlled and sustained drug release, improved patient compliance, and reduced side effects compared to traditional oral medications. The rising prevalence of chronic diseases requiring long-term medication regimens further accelerates market growth. Additionally, the ease of use and potential for self-administration align with patient preferences for at-home treatments. However, the market faces challenges, including the complexity of formulating drugs suitable for transdermal delivery and ensuring consistent and accurate dosing. Regulatory hurdles related to drug stability, patch adhesion, and manufacturing standards also pose challenges. Successful navigation of these challenges is crucial for stakeholders in the transdermal patch market to harness its growth potential and provide effective, user-friendly solutions for drug delivery needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Patch for Pain Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Hisamitsu
Viatris
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Segment by Type
Lidocaine Patch
Diclofenac Patch
Indomethacin Patch
Fentanyl Patch
Peppermint Patch
Methyl Salicylate Patch
Capsaicin Patch
Other
OTC
Rx
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Transdermal Patch for Pain Relief report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Transdermal Patch for Pain Relief market is projected to reach US$ 6315 million in 2029, increasing from US$ 4830.4 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transdermal Patch for Pain Relief market research.
The transdermal patch market is driven by the growing demand for convenient and non-invasive drug delivery methods. These patches offer advantages such as controlled and sustained drug release, improved patient compliance, and reduced side effects compared to traditional oral medications. The rising prevalence of chronic diseases requiring long-term medication regimens further accelerates market growth. Additionally, the ease of use and potential for self-administration align with patient preferences for at-home treatments. However, the market faces challenges, including the complexity of formulating drugs suitable for transdermal delivery and ensuring consistent and accurate dosing. Regulatory hurdles related to drug stability, patch adhesion, and manufacturing standards also pose challenges. Successful navigation of these challenges is crucial for stakeholders in the transdermal patch market to harness its growth potential and provide effective, user-friendly solutions for drug delivery needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Patch for Pain Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Hisamitsu
Viatris
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Segment by Type
Lidocaine Patch
Diclofenac Patch
Indomethacin Patch
Fentanyl Patch
Peppermint Patch
Methyl Salicylate Patch
Capsaicin Patch
Other
Segment by Application
OTC
Rx
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Transdermal Patch for Pain Relief report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices